Literature DB >> 10188674

Participant satisfaction and value in American Academy of Dermatology and American Cancer Society skin cancer screening programs in Massachusetts.

A C Geller1, A C Halpern, T Sun, S A Oliveria, D R Miller, R A Lew, H K Koh.   

Abstract

BACKGROUND: More than 1 million Americans have attended the American Academy of Dermatology's Melanoma/Skin Cancer Screening Programs since 1985. However, there have been no reports of the participants' perceived value, satisfaction, and benefits of skin cancer screening.
OBJECTIVE: We attempted to measure the benefits and subsequent screening practices of persons with presumptive positive screening diagnoses.
METHODS: A self-administered questionnaire was sent to participants with positive screening diagnoses in Massachusetts.
RESULTS: Of the 643 respondents, 81% rated their satisfaction as high and 84% had similar ratings for the value of the screening. Screenings apparently led to an increase in self-screening (60% before screening compared with 84% after screening).
CONCLUSION: Although screening appears to have relatively strong benefits, further studies should be conducted nationally.

Entities:  

Mesh:

Year:  1999        PMID: 10188674     DOI: 10.1016/s0190-9622(99)70438-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Screening and early detection of skin cancer.

Authors:  Kenneth G Linden
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

2.  Patient follow-up after participating in a beach-based skin cancer screening program.

Authors:  Mary L Greaney; Elaine Puleo; Alan C Geller; Stephanie W Hu; Andrew E Werchniak; Susan DeCristofaro; Karen M Emmons
Journal:  Int J Environ Res Public Health       Date:  2012-05-10       Impact factor: 3.390

3.  Time-trend of melanoma screening practice by primary care physicians: a meta-regression analysis.

Authors:  Antonis Valachis; Davide Mauri; Vassiliki Karampoiki; Nikolaos P Polyzos; Ivan Cortinovis; Georgios Koukourakis; Georgios Zacharias; Apostolos Xilomenos; Maria Tsappi; Giovanni Casazza
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.